Receptor tyrosine kinases, mainly epidermal growth factor receptor (EGFR) and platelet derived growth factor receptor (PDGFR), which are often aberrantly activated in GBM, have been linked to NF-κB activation. The gene discussed is NTRK1; the disease is glioblastoma.